Parnax Lab Limited has announced that its board of directors will meet on Thursday, May 28, 2026, at the company's registered office. The primary agenda of the meeting is to consider and approve the standalone and consolidated audited IND-AS compliant financial results for the quarter and year ended March 31, 2026. The approval is pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirements, 2015.

Agenda for the Meeting

The board will deliberate on the financial performance for the fourth quarter and the full fiscal year. The approved results, along with the auditor's report, will be submitted to the stock exchanges following the conclusion of the board meeting.

Trading Window Closure

In compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the company has closed the trading window for dealing in its equity shares. The closure is effective from April 1, 2026, for designated persons. The window will remain closed until 48 hours after the declaration of the audited financial results.

Parnax Lab Ltd. has submitted its mandatory quarterly compliance certificate to the Bombay Stock Exchange (BSE) for the quarter ended March 31, 2026, confirming regulatory adherence under SEBI (Depositories and Participants) Regulations, 2018.

Quarterly Compliance Filing Details

The pharmaceutical company filed the confirmation certificate on April 8, 2026, addressing the Department of Corporate Service (DCS-CRD) at BSE. The filing pertains to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting on dematerialization activities.

Dematerialization Status Confirmation

Parnax Lab confirmed through its registrar and transfer agent, MUFG Intime India Private Limited, that no dematerialization requests were received during the quarter ended March 31, 2026. This confirmation forms the basis of the compliance certificate submitted to the stock exchange.

The certificate was signed by Preet Kukreja, Company Secretary and Compliance Officer (ACS No.: 56761), ensuring proper authorization and compliance with corporate governance requirements.

Registrar Verification Process

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the company's registrar and transfer agent. The registrar provided the necessary confirmation regarding the absence of dematerialization requests during the reporting quarter, enabling Parnax Lab to fulfill its regulatory obligations.

Regulatory Compliance Framework

This quarterly filing represents part of the mandatory compliance framework established by SEBI for listed companies. The regulation requires companies to report on dematerialization activities and maintain transparency in share transfer processes. Such filings ensure proper record-keeping and regulatory oversight of securities transactions in the Indian capital markets.